KRT14 and breast cancer: Our lead working model postulates that changes in Krt14/Krt15 content alters BC behavior by modifying Sfn abundance, which, in turn, affects signal transduction cascades that balance proliferation and differentiation (i.e., dNp63 nuclear export and proteasomal degradation).